Cargando…
PAICS, a De Novo Purine Biosynthetic Enzyme, Is Overexpressed in Pancreatic Cancer and Is Involved in Its Progression
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with an extremely poor prognosis. There is an urgent need to identify new therapeutic targets and also understand the mechanism of PDAC progression that leads to aggressiveness of the disease. To find therapeutic targets, we analyzed da...
Autores principales: | Agarwal, Sumit, Chakravarthi, Balabhadrapatruni V.S.K., Kim, Hyung-Gyoon, Gupta, Nirzari, Hale, Kevin, Balasubramanya, Sai Akshaya Hodigere, Oliver, Patsy G., Thomas, Dafydd G., Eltoum, Isam-Eldin A., Buchsbaum, Donald J., Manne, Upender, Varambally, Sooryanarayana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229293/ https://www.ncbi.nlm.nih.gov/pubmed/32422575 http://dx.doi.org/10.1016/j.tranon.2020.100776 |
Ejemplares similares
-
PAICS, a Purine Nucleotide Metabolic Enzyme, is Involved in Tumor Growth and the Metastasis of Colorectal Cancer
por: Agarwal, Sumit, et al.
Publicado: (2020) -
A Role for De Novo Purine Metabolic Enzyme PAICS in Bladder Cancer Progression()
por: Chakravarthi, Balabhadrapatruni V.S.K., et al.
Publicado: (2018) -
Role and regulation of coordinately expressed de novo purine biosynthetic enzymes PPAT and PAICS in lung cancer
por: Goswami, Moloy T., et al.
Publicado: (2015) -
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses()
por: Chandrashekar, Darshan S., et al.
Publicado: (2017) -
Targeting P4HA1 with a Small Molecule Inhibitor in a Colorectal Cancer PDX Model()
por: Agarwal, Sumit, et al.
Publicado: (2020)